solidbio.com - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi SLDB
Solid Biosciences Inc. (SLDB) faces risks due to a rapid cash burn rate and the complexity of gene testing. However, the potential for multi-million dollar therapy pricing upon regulatory approval creates significant value. Demand is supported by the uniqueness of the vectors used to treat Duchenne muscular dystrophy. The current EBITDA_Co level reflects the operational cash flow dynamics, where the current mark is 0.00, allowing for an assessment of the issuer's financial stability.
Ringkesan rincian data analitis Solid Biosciences (SLDB)
- rega saham lan prakiraan rega para ahli:
- rincian nilai pasar emiten:
- informasi kapitalisasi buku:
- rincian struktur utang lan likuiditas bisnis:
Utang marang Modal Solid Biosciences Inc.|SLDB - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal Solid Biosciences Inc|SLDB - Gunggung utang perusahaan|Utang marang nilai buku Solid Biosciences|SLDB - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Solid Biosciences|Likuiditas darurat solidbio.com
- indikator pendapatan resik lan kelipatan nilai:
SLDB - Bathi resik perusahaan|Prakiraan bathi resik Solid Biosciences Inc.|SLDB - Pangali P/E|Prakiraan rega marang bathi solidbio.com|SLDB - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Solid Biosciences|SLDB - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan Solid Biosciences|SLDB - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan solidbio.com|SLDB - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Solid Biosciences Inc.
Ringkesan analitik perusahaan:SLDB - Solid Corp
To fundamentally assess the market status of Solid Biosciences Inc. (SLDB), it is critical to track the actual cash efficiency of the business. This indicator measures the daily inflow of operating funds before interest, and an analysis of actual EBITDA allows for the timely detection of stagnation in the gene therapy pipeline when the diversification of gene delivery technology platforms ceases to ensure the company's financial stability.
Karo sapa Solid Biosciences Inc. saingan
TEM: Bathi operasional sadurunge amortisasi|QGEN: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi IONS (ionispharma.com)|RGEN: Bathi operasional EBITDA|RNA (Avidity Biosciences Inc) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CRSP (CRISPR Therapeutics Corp) - Bathi operasional EBITDA|GeneDx Corp (WGS) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Ultragenyx Pharmaceutical (RARE)|BEAM - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Sarepta SRPT|Pendapatan operasional sadurunge ngurangi amortisasi Twist Bioscience Inc (TWST)|10x Genomics Corp - Bathi operasional EBITDA|Intellia Corp (NTLA) - Bathi operasional sadurunge ngurangi amortisasi|STOK: Bathi operasional EBITDA|BLFS - Pendapatan operasional sadurunge ngurangi amortisasi|WVE (Wave Life Sciences Ltd.) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Maze Therapeutics, Inc. MAZE|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Sionna Pharma (SION)|Prime Medicine Bio - Bathi operasional sadurunge amortisasi|Bathi operasional EBITDA TSHA (Taysha Gene Therapies)|QURE - Bathi operasional sadurunge ngurangi amortisasi|MeiraGTx - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi REGENXBIO Inc|Ocugen Corp (OCGN) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|PACB - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi BNTC|DSGN: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA RCKT|Pendapatan operasional sadurunge ngurangi amortisasi 4DMT|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Lexeo Therapeutics, Inc. LXEO|KRRO: Bathi operasional sadurunge amortisasi|Editas Medicine, Inc. - Bathi operasional EBITDA|silence-therapeutics.com (SLN) - Bathi operasional sadurunge ngurangi amortisasi|PRQR (proqr.com) - Bathi operasional sadurunge ngurangi amortisasi|CDXS - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Sangamo|Nautilus Biotechnology Inc (NAUT) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Metagenomi, Inc. (MGX)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi DTIL (precisionbiosciences.com)|Bathi operasional EBITDA GBIO (Generation Bio)|BOLD: Bathi operasional sadurunge amortisasi|Exicure Corp - Bathi operasional EBITDA|IMNN: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|PHIO: Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi MBIO|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TransCode Therapeutics Inc.|Bathi operasional sadurunge amortisasi BNGO (Bionano)|Bathi operasional EBITDA APDN|Bathi operasional EBITDA bluebird bio, Inc (BLUE)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi ImmunoPrecise Antibodies Ltd. IPA|Pendapatan operasional sadurunge ngurangi amortisasi omegatherapeutics.com (OMGA)|OMIC - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Regulus Therapeutics, Inc.|Syros (SYRS) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|TBIO (Telesis Bio, Inc) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|TCON (TRACON Pharmaceuticals) - Bathi operasional EBITDA|unitybiotechnology.com (UBX) - Pendapatan operasional sadurunge ngurangi amortisasi
